Analytical innovation: meeting the demands of commercial viral vector manufacture

As with most truly ground-breaking areas of innovation in the human medicines arena, the gene therapy field has not enjoyed a smooth transition into the commercial industrialized setting. As regulators and industry alike strive to build a deeper understanding of the underpinning biological and manufacturing process-related factors impacting the safety and efficacy of viral vector-driven products, the spotlight has fallen squarely on the analytical technology field. This eBook features a curated selection of content that explores the various challenges and drivers that are shaping the CMC and quality landscape for adeno-associated viral (AAV) and lentiviral (LV) vectors alike. It provides a uniquely broad yet detailed review some of the cutting-edge analytical tools that can deliver the insights and evidence required if the gene therapy field is to achieve lasting commercial success.

Please enter your email to access content Read now